NFE2L2 and esophageal squamous cell carcinoma: We subsequently applied different ESCC cells bearing distinct genetic background (e.g.P53, EGFR, CDKN2A, NFE2L2 status) to engineer RBM4 expression by infecting with overexpression or knockdown lentivirus.